3 active trials 0 recruiting 7 disease areas
| First posted | New trial filing | Phase | Status |
|---|---|---|---|
| 2026-09-03 | NCT07802717 A Phase 1 Dose-escalation and Expansion Study of In Vivo BCMA-CAR T Cell Therapy (VV169)… | Phase 1 | Not Yet Recruiting |
| Phase 1 | 1 | |
| Phase 1/2 | 1 | |
| Phase 2 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT04291105 | Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients | Melanoma | Active, Not Recruiting | 2026-07-08 |
| Phase 1/2 | ||||
| NCT03647163 | Ph I/II Trial of Systemic VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy… | Solid Tumor | Active, Not Recruiting | 2025-09-16 |
| Phase 1 | ||||
| NCT07802717 | A Phase 1 Dose-escalation and Expansion Study of In Vivo BCMA-CAR T Cell Therapy (VV169)… | Multiple Myeloma Refractory | Not Yet Recruiting | 2026-09-03 |
Colorectal Cancer (1) · Head & Neck Cancer (1) · Kidney Cancer (1) · Lung Cancer (1) · Melanoma (1) · Multiple Myeloma (1) · Non-Small Cell Lung Cancer (NSCLC) (1)